CYP2B6 c.451_452delinsAT ;(p.Q151M)

Variant ID: 19-41510318-CA-AT

NM_000767.4(CYP2B6):c.451_452delinsAT;(p.Q151M)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Approved HIV reverse transcriptase inhibitors in the past decade.

Acta Pharmaceutica Sinica. B
Li, Guangdi G; Wang, Yali Y; De Clercq, Erik E
Publication Date: 2022-04

Variant appearance in text: CYP2B6: Q151M
PubMed Link: 35847492
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Sensitive assessment of the virologic outcomes of stopping and restarting non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.

Plos One
Geretti, Anna Maria AM; Fox, Zoe Z; Johnson, Jeffrey A JA; Booth, Clare C; Lipscomb, Jonathan J; Stuyver, Lieven J LJ; Tachedjian, Gilda G; Baxter, John J; Touloumi, Giota G; Lehmann, Clara C; Owen, Andrew A; Phillips, Andrew A; ,
Publication Date: 2013

Variant appearance in text: CYP2B6: Q151M
PubMed Link: 23874928
Variant Present in the following documents:
  • Main text
  • pone.0069266.pdf
View BVdb publication page